Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 18.276% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) NS(=O)(=O)c1ccc(NC(=S)NNC(=O)c2ccc(Br)o2)cc1
b) Cc1ccc(S(=O)(=O)N2CCCCC2)cc1NC(=O)CSCC(=O)O
c) O=C(O)CCSc1nc2ccccc2n1CCOc1ccccc1
Answer: b. Cc1ccc(S(=O)(=O)N2CCCCC2)cc1NC(=O)CSCC(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(S(=O)(=O)N2CCCCC2)cc1NC(=O)CSCC(=O)O
Cc1ccc(S(=O)(=O)N2CCCCC2)cc1NC(=O)CSCC(=O)O
2-[2-(2-methyl-5-piperidin-1-ylsulfonylanilino)-2-oxoethyl]sulfanylacetic acid